Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of FAS (CD95/APO-1) and FAS ligand in lung cancer, its prognostic and predictive relevance

21 Jun 1999

Abstract excerpt

In order to examine whether or not the expression of the apoptosis-related receptor Fas (CD-95/APO-1) and its ligand (FasL) has relevance for patient survival, immunohistochemistry was used to analyze the proteins of both factors in 164 non-small cell lung carcinomas. Patients with Fas-positive tumors exhibited significantly longer survival times than patients with Fas-negative carcinomas. In contrast, FasL did...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer-related Molecular Pathways
Share to Cancer Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10371340
DOI: 10.1002/(sici)1097-0215(19990621)84:3<239::aid-ijc7>3.0.co;2-s

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of FAS (CD95/APO-1) and FAS ligand in lung cancer, its prognostic and predictive relevancePMID 10371340Read ↗

Alterations of Fas (APO-1/CD 95) gene and its relationship with p53 in non small cell lung cancer.Semantic proximity Read ↗

Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer.Semantic proximity Read ↗

Fas and Fas ligand as prognostic factors in human breast carcinoma.Semantic proximity Read ↗

Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer.Semantic proximity Read ↗

Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.Semantic proximity Read ↗

Defining CD95 as a tumor suppressor gene.Semantic proximity Read ↗

Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.Semantic proximity Read ↗

Fas receptor-mediated apoptosis: a clinical application?Semantic proximity Read ↗

[Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].Semantic proximity Read ↗

Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapy.Semantic proximity Read ↗

Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.Semantic proximity Read ↗

Does CD95 have tumor promoting activities?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.